Napier Park Global Capital (US)’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-181,925
Closed -$48.8M 24
2016
Q1
$48.8M Buy
181,925
+152,950
+528% +$43.8M 18.3% 1
2015
Q4
$9.05M Buy
28,975
+6,500
+29% +$1.94M 4.96% 3
2015
Q3
$6.11M Sell
22,475
-5,000
-18% -$1.54M 3.66% 4
2015
Q2
$8.34M Sell
27,475
-5,290
-16% -$1.58M 2.94% 6
2015
Q1
$9.75M Buy
32,765
+2,470
+8% +$704K 3.29% 5
2014
Q4
$7.8M Sell
30,295
-13,518
-31% -$3.38M 2.32% 8
2014
Q3
$10.6M Buy
43,813
+17,328
+65% +$3.88M 3.59% 5
2014
Q2
$5.91M Buy
+26,485
New +$5.48M 2.46% 17

Other funds holding AGN

Napier Park Global Capital (US)'s AGN Position: Q2 2016 in Review

Napier Park Global Capital (US) sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 181,925 shares — an estimated $48.8M sold.

Napier Park Global Capital (US) first reported a position in AGN in Q2 2014 and held it in 8 quarters. The position peaked at $48.8M in Q1 2016. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Napier Park Global Capital (US) reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • Napier Park Global Capital (US) sold 181,925 Allergan plc shares in Q2 2016, an estimated $48.8M.
  • Napier Park Global Capital (US) first reported a position in Allergan plc in Q2 2014 and held it in 8 quarters.
  • Napier Park Global Capital (US)'s Allergan plc position peaked at $48.8M in Q1 2016.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Napier Park Global Capital (US)'s 13F filing for Q2 2016, filed 11 Aug 2016.